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Abstract. Functional dyspepsia (FD) is a non‑organic gastrointestinal disorder that has a marked negative impact on quality
of life. Compared with conventional pharmacological therapies, the traditional Chinese medicine weikangning (WKN)
is a safe and effective treatment for FD. The present study
aimed to determine the molecular mechanisms underlying
the efficacy of WKN. The effect of different concentrations
of WKN on the proliferation of the human gastric mucosal
epithelial cell line GES‑1 was assessed. The optimal WKN
concentration to promote cell proliferation was determined,
and this concentration was used to examine the effect of WKN
compared with a domperidone‑treated positive control group
on the antioxidant capacity of GES‑1 cells. The effect of WKN
treatment on the growth and antioxidant activity of GES‑1 cells
was also assessed following nuclear factor erythroid 2 like 2
(Nrf2) knockdown. The optimal WKN dose for promoting cell
growth was determined to be 0.025 mg/ml; at this concentration the expression of the antioxidant proteins glutathione
S‑transferase P and superoxide dismutase 2 (SOD2) were
significantly elevated (P<0.0001). Furthermore, the amount of
reduced glutathione and activity of SOD2 were significantly
increased (P<0.0001 and P<0.01, respectively), and malondialdehyde content was significantly decreased, compared with
the controls (P<0.001). With WKN treatment, the transcription
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of Nrf2 and its downstream genes were significantly upregulated (P<0.01), and the level and nuclear distribution of
Nrf2 protein was also markedly increased. Following Nrf2
silencing, the protective antioxidant effects of WKN treatment were impaired and GES‑1 cell proliferation decreased.
The results of the present study suggest that the efficacy of
WKN in protecting gastric mucosal epithelial cells in FD is
antioxidant‑dependent and mediated by Nrf2 activation.
Introduction
Functional dyspepsia (FD) is a non‑organic gastrointestinal
(GI) disorder with persistent or recurrent sensations of early
satiety, post‑prandial fullness, nausea, and pain or discomfort
in the upper abdomen (1,2). According to recent statistics,
FD affects 5‑11% of the population worldwide (3). Although
FD is not a life‑threatening disease, it necessitates numerous
medical treatments and places a significant economic burden
on patients (4). Furthermore, it has been reported that FD may
develop into peptic ulceration (5).
Uncovering the pathogenesis of FD may contribute to the
development of successful intervention strategies, which may
in turn prevent symptomatic exacerbations of the disease and
potentially even restore the digestive system to normal. There
are a number of theories regarding the potential causes of FD,
including genetic factors, infection with Helicobacter pylori,
neurologic‑hormonal disorders, autonomic disorders, stress
and mental disorders, visceral hypersensitivity, and altered
duodenal sensitivity to acids and lipids (1).
Several studies have explored the potential causes of
FD, and efforts have been made to identify effective treatments; however, the optimal therapy for FD is yet to be
determined (6). The majority of pharmacologic treatments
that are currently available for FD have demonstrated limited
efficacy (7). Several 5‑hydroxytryptamine agonists, including
tegaserod, cisapride, mosapride, pukabili, and renzapride,
have demonstrated excellent efficacy in the treatment of FD
via regulating GI dynamics; however, their safety has not been
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adequately demonstrated (8). For example, evidence indicates
that tegaserod may increase the risk of myocardial infarction,
sudden cardiac death and other cardiovascular events (9,10).
By contrast, cisapride may lead to QT interval prolongation,
ventricular tachycardia and cardiac arrest (11).
The traditional Chinese medicine (TCM) weikangning
(WKN) is a representative formula based on the classical
TCM theory of ‘Xi Kai Ku Jiang’ (12). Several studies from
the past decade have reported that WKN is a safe and effective treatment for FD (12,13). The composition of WKN
includes the following nine Chinese herbs: Radix Scutellariae,
Rhizoma Zingiberis, Radix Codonopsis pilosulae, Rheum
rhabarbarum, Radix Bupleuri, Radix Curcumae, Magnolia
officinalis bark, Radix Paeoniae alba, and Rhizoma
Corydalis (12). Pharmacological studies have indicated that
Pinellia spp., Radix Codonopsis pilosulae, Villosum spp.,
Magnolia officinalis and Rheum rhabarbarum may strengthen
GI smooth muscle tension (14‑19). Furthermore, Scutellaria
baicalensis and Coptis chinensis have been reported to function as anti‑inflammatory and antiallergic mediators, and
serve a dual‑directional role in the regulation of GI smooth
muscle, which may provide a pharmacological basis for WKN
as a treatment for FD (20‑22).
To learn more about the detailed molecular mechanism
underlying the efficacy of WKN in the treatment of FD, our
group previously conducted a proteomic study to identify the
differences in GI protein expression in an FD rat model with
and without WKN treatment (12). The results revealed that
the protein expression levels of glutathione‑S‑transferase P
(GSTP1) and superoxide dismutase 2 (SOD2) were decreased
in the disease model group compared with the normal control
group. However, following the administration of WKN, the
expression of GSTP1 and SOD2 was enhanced.
According to previous studies, GSTP1 and SOD2 serve
an important role in combating oxidative stress (23,24). For
example, Wang et al (23) demonstrated that upregulating
the expression of GSTP1 and SOD2 significantly decreased
oxidative stress by reducing reactive oxygen species (ROS)
formation. In addition, a study by Dato et al (24) reported
that genes belonging to pro‑antioxidant signaling pathways,
including GSTP1 and SOD2, were positively associated
with longevity and functional status in very old age. Based
on such observations and preliminary work by our group, it
was hypothesized that oxidative stress may be an important
component of the pathological mechanism of FD and that
the efficacy of WKN may be due to reduced levels of oxidative stress. The results of these previous studies suggest that
WKN may protect human GI cells by increasing antioxidant
capacity, thereby maintaining the survival and growth of these
cells and promoting recovery from FD. In addition, a previous
study revealed that Nrf2 pathway played a critical role in
antioxidation, anti‑inflammation and protecting liver from
oxidative damages in dyspepsia (25). Based on these results, it
was investigated in the current study whether the antioxidant
regulation of Nrf2, GSTP1 and SOD2 was involved underlying
the WKN treatment for FD. Overall, the present study aimed
to provide a theoretical basis for the use of TCMs in the treatment and prevention of FD, and to provide experimental data
to support the hypothesis that oxidative injury is important in
the development and exacerbation of FD.

Materials and methods
Cell culture. The human gastric mucosal epithelial cell
line GES‑1 was purchased from the cell bank of Culture
Preservation Committee, Chinese Academy of Sciences
(Beijing, China). GES‑1 cells were cultured in RPMI‑1640
medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA,
USA) containing 10% heat inactivated fetal bovine serum
(Zhejiang Tianhang Biological Technology Co., Ltd., Zhejiang,
China), 100,000 U/l penicillin and 100 mg/l streptomycin in
an atmosphere containing 5% CO2 at 37˚C.
Establishment of the lentivirus‑mediated nuclear factor
erythroid 2 like 2 (Nrf2) gene‑knockdown stable strain of
GES‑1 cells. Four pairs of short hairpin (sh)RNA species
targeting Nrf2 mRNA were designed by Origene Technologies
(Rockville, MD, USA; Table I) and cloned into Lenti‑KD
vectors (Pre‑1102; Beijing Pregene Science and Technology
Co., Ltd., Beijing, China) with blank vectors as controls. Using
Lipofectamine® 2,000 Transfection reagent (Thermo Fisher
Scientific, Inc.), these plasmids, along with the pMD2.0G
and psPAX2 plasmids (both Addgene, Cambridge, MA,
USA), were successively transfected into 293T cells (ATCC,
Manassas, VA, USA) to form a virus package. After each type
of transfected 293T cells were cultured in 5% CO2 at 37˚C
for 3 days, a 2 ml culture of supernatant‑containing lentiviral
particles was harvested by centrifugation at a speed of 300 x g
at 4˚C for 5 min, and stored at ‑80˚C until required.
A total of 2x105 GES‑1 cells were seeded into a 6‑well
plate. Following overnight culture, the adherent cells were
transfected at room temperature with the lentivirus‑containing
culture medium overnight, and cultured at 30˚C in a 5% CO2
incubator. The following day, the medium was replaced. At
48‑72 h following transfection, 3 µg/ml puromycin was added
for selection and the cells were sub‑cultured in a 10 cm2 plate,
with continued puromycin treatment. The Nrf2 expression
of transduced cells was identified using western blotting as
described below.
The gene knockdown mediated by the lentivirus with the
shNrf2‑3 sequence appeared to be the most effective (Fig. 1).
The GES‑1 cell strain transfected with this lentivirus was cryopreserved at ‑80˚C as the Nrf2 gene‑knockdown stable strain,
which is referred to as shNrf2 throughout the present study.
At the same time, the GES‑1 cells transfected with lentivirus
containing shMock sequence (CCTA AGGTTA AGTCGCCC
TCG) were cryopreserved and used as a control (shMock).
After recovery, the culture conditions for the stable cell lines
were the same as those described for the GES‑1 cells above.
Drug preparation. WKN was prepared using the following
ingredients: Rhizome Pinelliae Preparata, 9 g; Rhizoma
Coptidis, 5 g; Radix Scutellariae, 9 g; Fructus Amomi villosi,
6 g; Rhizoma Zingiberis, 9 g; Radix C. pilosulae, 15 g; Radix
Curcumae, 9 g; M. officinalis bark, 9 g; Rhizoma Corydalis
vinegar, 10 g; Radix Bupleuri, 9 g; rhubarb, 6 g; fried almond,
9 g; inflammatory licorice, 9 g; Radix Paeoniae Alba, 15 g; and
Fructus Ziziphi jujubae, 4 g. All components were supplied by
the Department of Pharmacy of Wangjing Hospital of China
Academy of Chinese Medical Sciences (Beijing, China). WKN
was decocted according to traditional methods. The WKN was
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Table I. Sequences of shRNAs targeting Nrf2 mRNA.
Oligo
shNrf2‑1
shNrf2‑2
shNrf2‑3
shNrf2‑4

Sequence
F: 5'‑GATCCGCACCTTATATCTCGAAGTTTCTTCCTGTCAGAAAACTTCGAGATATAAGGTGCTTTTTG‑3'
R:5'‑AATTCAAAAAGCACCTTATATCTCGAAGTTTTCTGACAGGAAGAAACTTCGAGATATAAGGTGCG‑3'
F: 5'‑GATCCCCGGCATTTCACTAAACACAACTTCCTGTCAGATTGTGTTTAGTGAAATGCCGGTTTTTG‑3'
R:5'‑AATTCAAAAACCGGCATTTCACTAAACACAATCTGACAGGAAGTTGTGTTTAGTGAAATGCCGGG‑3'
F: 5'‑GATCCCCCTGTTGATTTAGACGGTATCTTCCTGTCAGAATACCGTCTAAATCAACAGGGTTTTTG‑3'
R:5'‑AATTCAAAAACCCTGTTGATTTAGACGGTATTCTGACAGGAAGATACCGTCTAAATCAACAGGGG‑3'
F:5'‑GATCCGCAGCAAACAAGAGATGGCAACTTCCTGTCAGATTGCCATCTCTTGTTTGCTGCTTTTTG‑3'
R:5'‑AATTCAAAAAGCAGCAAACAAGAGATGGCAATCTGACAGGAAGTTGCCATCTCTTGTTTGCTGCG‑3'

shRNA, short hairpin RNA; Nrf2, nuclear factor erythroid 2 like 2; F, forward; R, reverse.

20 µl CCK‑8 solution (Beyotime Institute of Biotechnology,
Haimen, China) was added to the wells. Cells were then
cultured at 37˚C for 1 h. Optical density was measured at
450 nm using a microplate reader (POLARstar® Omega; BMG
Labtech GmbH, Ortenburg, Germany). Four replicates were
performed at each time‑point for each group.
Figure 1. Expression of Nrf2 protein in GES‑1 cell strains transfected with
four types of shRNA or control shRNA. The expression of Nrf2 protein was
assessed by western blotting. shRNA, short hairpin RNA; Nrf2, Nrf nuclear
factor erythroid 2 like 2.

immersed in water for 30 min, then 500 ml water was added and
decocted for 30 min; the extract of ~150 ml was poured out, and
another 500 ml water was added followed by decocting again;
finally the extract of the two steps were mixed, at a total volume
of 300 ml. The solution was condensed to a volume of 400 ml.
The 400 ml crude extract solution was vacuum lyophilized for
at least 3 h to obtain a powder using a freeze dryer (ALPHA1‑4,
Martin Christ GmbH, Osterode, Germany). The powder was
stored until use at ‑20˚C, and was dissolved in PBS to make the
stock solution (10 mg/ml). The stock solution was sterilized using
60
Co‑γ radiation (26) and centrifuged at 15,000 x g, 37˚C for
20 min to remove the insoluble ingredients. The stock solution
was stored at ‑20˚C and diluted to varying degrees depending
on the concentration required for the different experimental
procedures.
Domperidone (Sigma‑Aldrich; Merck KGaA, Darmstadt,
Germany) was dissolved in dimethyl sulfoxide (Sigma‑Aldrich;
Merck KGaA) to create a stock solution (0.1 mol/l) and a
working solution (2.5 µmol/ml), and was used as a positive
control. PBS was used as the negative control. The drug treatment groups varied depending on the different experimental
procedures, as outlined below.
Proliferation activity assays
Cell Counting Kit‑8 (CCK‑8) assay. A total of 1x104 GES‑1
cells/well were seeded into a 96‑well plate. The cells were
then cultured in an atmosphere containing 5% CO2 at 37˚C
for 4‑6 h. Drug treatments were administered following adherence. Cells were divided into 10 groups and WKN was added
at different concentrations (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5,
0.6 and 0.7 mg/ml). After 12, 24 and 48 h of incubation at 37˚C,

MTS assay. A total of 5x10 4 shMock or shNrf2 cells/well
were seeded into a 96‑well plate. The cells were then cultured
with 5% CO2 at 37˚C for 4‑6 h. The drug treatment was
performed following adherence. Cell culture media containing
0.025 mg/ml WKN or equivalent amounts of PBS (as a blank
control) was added to the wells. After 4, 48 and 96 h of
incubation, 20 µl MTS solution (Beijing Pregene Science and
Technology Co., Ltd., Beijing, China) was added to the wells.
Cells were then cultured at 37˚C for 1 h. Optical density was
measured at 490 nm using the microlate reader. Six replicates
were performed at each time point for each group.
Reverse transcription‑quantitative polymerase chain reaction
(RT‑qPCR) analysis. A total of 1.5x106 cells/well were seeded
into a 6‑well plate. The cells were cultured with 5% at 37˚C
for 4‑6 h. The drug treatments (see the corresponding figure
legend for the specific group settings and processing times)
were performed following adherence. After treatment, total
RNA was extracted using TRIzol reagent (Thermo Fisher
Scientific, Inc.) and RT was performed using a Prime Script™
RT reagent kit (Takara Bio, Inc., Shiga, Japan) according to
the manufacturer's protocol. PCR primers were synthesized by
Shanghai Biotech Co., Ltd. (Shanghai, China) and are listed in
Table II. The reaction was kept on ice in the dark until qPCR
was performed and was comprised of the following components: 10 µl 2X SYBR Premix Ex Taq™ (Takara Bio, Inc.),
0.5 µl PCR forward primer (10 µM), 0.5 µl PCR reverse primer
(10 µM), 2 µl cDNA template and 7 µl distilled H2O. The thermocycling conditions were as follows: Initial denaturation at
95˚C for 1 min; 40 cycles of 95˚C for 15 sec, 60˚C for 15 sec
and 72˚C for 45 sec; and a final extension at 72˚C for 5 min.
Relative mRNA expression was calculated using the 2‑∆∆ Cq
method (27). β‑actin was used as the internal reference gene.
Western blotting. A total of 1.5x106 cells/well were seeded into
a 6‑well plate and cultured with 5% CO2 at 37˚C for 4‑6 h.
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Drug treatments (see the corresponding figure legend for the
specific group settings and processing times) were administered following adherence. Total protein was extracted when
cells were collected. After ultrasonic homogenization in the
RIPA lysis buffer (150 µl; Applygen Technologies, Inc., Beijing,
China), cells were lysed at 4˚C for another 10 min, centrifuged
(15,000 x g, 4˚C, 15 min), and the supernatant was transferred
for analysis. Then protein was quantified using a BCA Protein
Quantification kit (Beijing Biomed Biological Technology
Co., Ltd., Beijing, China). Protein was denatured at 100˚C for
5 min, and 20‑40 µg of protein samples were loaded Next,
SDS‑PAGE was performed using the following settings: 4%
stacking gel, 80 V for 30 min; and a 12% resolving gel, 120 V
for 1 h. Proteins were then electrotransferred onto PVDF
membranes. The membranes were blocked with 5% nonfat
milk in Tris‑buffered saline (pH 7.5) with 0.1% Tween‑20
for 1 h at room temperature. Primary antibodies directed
against the following proteins were used: GSTP1 (P04906,
Enzo Life Sciences, Farmingdale, NY, USA; 1:1,000), SOD2
(2299‑1, Epitomics; Abcam, Cambridge, UK; 1:1,000),
Nrf2 (ab62352, Abcam; 1:1,000), and β‑actin (4970S, rabbit
monoclonal antibody; Cell Signaling Technology, Danvers,
MA, USA; 1:5,000). The membrane was incubated with the
primary antibodies at 4˚C overnight. The secondary horseradish peroxidase‑conjugated immunoglobulin G antibody
(ZB‑2301; 1:3,000) was purchased from Zhongshan Jinqiao
Biotechnology Co., Ltd. (Beijing, China). The membrane was
incubated with the secondary antibodies at room temperature
for 1 h. Protein bands were visualized using an enhanced electrochemiluminescence western blot high‑sensitivity detection
kit (CW0049 M, Beijing Comwin Biotech Co., Ltd., Beijing,
China) and images were captured using the Gel Doc™ XR
Gel Imaging system (Bio‑Rad Laboratories, Inc., Hercules,
CA, USA). Semi‑quantitative analysis was performed using
ImageJ 1.47 software (National Institutes of Health, Bethesda,
MA, USA). The results are presented as percentages relative to
the control groups.
Immunofluorescent staining. GES‑1 cells were seeded into
a culture dish with pretreated coverslips at a density of 105
cells/500 µl. After adherence, 0.025 mg/ml WKN was added
to the experimental groups, while an equivalent amount of
PBS was added to the control group. After 24 h of treatment
at 37˚C, the cells were harvested. The slides were soaked
in PBS 3 times (3 min/soak) and fixed at room temperature
for 15 min using 4% paraformaldehyde. Slides were subsequently soaked in PBS 3 times (3 min/soak) and penetrated
with 0.5% Triton X‑100 (in PBS) for 20 min at room temperature. Next, the slides were soaked in PBS and blotted dry.
Subsequently, the slides were blocked with 6% normal goat
serum (HyClone; GE Healthcare Life Sciences, Logan, UT,
USA) in PBS for 20 min at room temperature. The blocking
solution was removed and the slides were treated with primary
antibodies directed against Nrf2 (ab137550, Abcam; 1:40)
overnight at 4˚C. The slides were then rewarmed at 37˚C for
45 min, soaked in PBS 3 times (3 min/soak) and blotted dry.
A fluorescent secondary antibody, goat anti‑rabbit IgG H&L
Alexa Fluor ® 647 (ab150079; Abcam; 1:800), was added
and the slides were incubated for 30 min at 37˚C. The slides
were soaked in PBS 3 times (3 min/soak) and blotted dry.

Table II. Primers used in reverse transcription‑quantitative
polymerase chain reaction.
Target
gene
GSTP1
SOD2
Nrf2
NQO1
HO‑1
GCLM
GCLC
β‑actin

Sequence
F: 5'‑GGCTCTATGGGAAGGACCAGC‑3'
R: 5'‑CACATAGTCATCCTTGCCCGCC‑3'
F: 5'‑TCAGCCCTAACGGTGGTGGA‑3'
R: 5'‑AAGCCAACCCCAACCTGAGC‑3'
F: 5'‑AGCATGCTACGTGATGAAGATGG‑3'
R: 5'‑AGCTCAGAAAAGGTCAAATCCTCC‑3'
F: 5'‑CATCCCAACTGACAACCAGAT‑3'
R: 5'‑CAGGGAAGCCTGGAAAGATAC‑3'
F: 5'‑ATGACACCAAGGACCAGAGC‑3'
R: 5'‑GCATAAAGCCCTACAGCAACT‑3'
F: 5'‑CACGAGGTCAGGAGTTTGAGA‑3'
R: 5'‑AGCTGAGATTACAGGCGAGTG‑3'
F: 5'‑CCCTCCTCCAAACTCAGACAT‑3'
R: 5'‑TGGTGAGCAGTACCACAAACA‑3'
F: 5'‑GCTGCCCTGAGGCACTCTTC‑3'
R: 5'‑ATCCTGTCGGCAATGCCAGG‑3'

GSTP1, glutathione‑S‑transferase P; SOD2, superoxide dismutase 2;
Nrf2, ���������������������������������������������������������
nuclear factor erythroid 2 like 2; NQO1, ����������������
NADPH dehydrogenase quninone 1; HO, heme oxygenase; GCLM, glutamate cystteine
ligase modifier subunit; GCLC, glutamate cysteine ligase catalytic
subunit; F, forward; R, reverse.

The slides were treated with DAPI dye (Beyotime Institute
of Biotechnology) at room temperature in the dark for 5 min
to stain the cell nuclei. The slides were then washed with
PBS 4 times (5 min/wash), sealed with mounting medium
containing anti‑fluorescence quenching reagent (Antifade
Mounting Medium; Beyotime Institute of Biotechnology)
and the edges were sealed with nail polish. The slides were
observed under a fluorescence microscope and representative
images were captured.
Detection of oxidative stress levels. Cells were lysed
following drug treatment (see the corresponding figure legend
for the specific group settings and processing times). The
culture medium was removed and the cells were rinsed with
pre‑cooled PBS twice. Pre‑cooled PBS (1 ml) was added and
cells were swept with a cell lifter, then transferred into a 1.5 ml
microcentrifuge tube. Centrifugation was performed at 4˚C
and at 650 x g for 15 min. The sediment was harvested and
cytopreserved at ‑80˚C. Different aspects of oxidative stress
were detected using a reduced glutathione (GSH) content
assay kit [intra‑assay coefficient of variation (CV), 1.2%;
inter‑assay CV: 3.86%; sensitivity, 0.3‑147.1 mg/l], a SOD
enzyme activity assay kit (intra‑assay CV, 5.05%; inter‑assay
CV, 3.32%; sensitivity, 0.5 U/ml), and a maleic dialdehyde
(MDA) content assay kit (intra‑assay CV, 3.5%; inter‑assay CV,
4.11%; sensitivity, 0.5‑113 nmol/ml). All kits were provided by
Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
Cell lysis, the detection procedure and result calculations were
all performed according to the manufacturer's protocol.
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Statistical analysis. All experiments were repeated
≥3 times, and the results were analyzed using SPSS software
(version 19.0; IBM Corp., Armonk, NY, USA). Data are represented as the mean ± standard deviation. Student's t‑test was
used to analyze differences between two groups. P<0.05 was
considered to indicate a statistically significant difference.
Results
Low concentrations of WKN promote GES‑1 cell proliferation.
A CCK‑8 assay was used to investigate cell proliferation and it
was demonstrated that WKN at lower concentrations had the
optimal effect in promoting the proliferation of GES‑1 cells at
all time points (Fig. 2). The pro‑proliferative effects gradually
weakened with an increase in the concentration of WKN. The
optimal effect was observed at 0.025 mg/ml.
Low concentrations of WKN increase the expression of
GSTP1 and SOD2 in GES‑1 cells. In our previous study
of WKN treatment in FD model rats, proteomics were
analyzed, and it was demonstrated that GSTP1 and SOD2
expression levels were decreased in the disease model group
and upregulated following WKN treatment (12). It was therefore speculated that the growth‑promoting effect of WKN
treatment on GES‑1 cells may be associated with the expression of GSTP1 and SOD2. Therefore, in the present study
changes in GSTP1 and SOD2 expression following WKN
treatment were investigated. Following treatment with WKN
at different concentrations for 24 h, the expression level of
GSTP1 mRNA in GES‑1 cells was significantly elevated
compared with the control group (P<0.05; Fig. 3A). However,
no significant difference was observed between the domperidone treatment group and the control group (Fig. 3A).
Although domperidone treatment significantly enhanced
SOD2 mRNA levels (P<0.05; Fig. 3A), and GSTP1 and SOD2
protein levels (P<0.0001 and P<0.001, respectively; Fig. 3B),
compared with the control group, 0.025 mg/ml WKN had
a greater effect (P<0.0001; Fig. 3B). As the concentration
of WKN increased, its effect on GSTP1 and SOD2 mRNA
and protein levels decreased (Fig. 3). These results further
confirmed that the efficacy of WKN is concentration‑dependent. When the concentration of WKN was 0.025 mg/ml, the
protective effect on GES‑1 cells of promoting cell growth,
and increasing GSTP1 and SOD2 expression levels, was the
greatest. Therefore, this was chosen as the optimal concentration for subsequent experiments.
WKN decreases oxidative stress in GES‑1 cells. GSTP1 and
SOD2 serve important roles in combating oxidative stress. It
was therefore hypothesized that the growth‑promoting effect
of WKN on gastric mucosal epithelial cells was associated
with the regulation of oxidative stress. The GSH content, SOD
activity and MDA content were measured as a proxy for the
level of cellular oxidative stress (Fig. 4). When GES‑1 cells
were treated with 0.025 mg/ml WKN, GSH content and SOD
activity increased significantly (P<0.0001 and P<0.01, respectively), while MDA content decreased significantly (P<0.001),
compared with the control group. However, no significant
changes in oxidative stress index levels were observed in the
domperidone treatment group.

Figure 2. Proliferation GES‑1 cells after 12, 24 or 48 h of WKN treatment
at different concentrations (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 and
0.7 mg/ml) detected using the Cell Counting Kit‑8 assay. WKN, weikangning.

WKN increases the expression of Nrf2 and its target genes
in GES‑1 cells. A previous study identified gstp1 and sod2
as two of the putative Nrf2‑dependent genes (27) and Nrf2
has been identified as an important transcription factor that
regulates oxidative stress (28‑32). To determine whether WKN
treatment enhanced the antioxidant capacity of cells via the
promotion of Nrf2, GES‑1 cells were treated with 0.025 mg/ml
WKN and the expression level of the Nrf2 gene was measured
as the processing time increased. The transcription level of
Nrf2 was significantly upregulated following 2 h of WKN
treatment (P<0.001; Fig. 5A). This effect decreased with time.
The transcription levels of four target genes of Nrf2 (NADPH
dehydrogenase quninone 1, heme oxygenase 1, glutamate
cysteine ligase modifier subunit and glutamate cysteine ligase
catalytic subunit) were measured after 2 h (data not shown) and
4 h (Fig. 5B) of treatment with 0.025 mg/ml WKN. The results
demonstrated that the transcription of the four genes increased
significantly following 4 h of treatment (P<0.01; Fig. 5B).
WKN increases GES‑1 cell Nrf2 content and nuclear trans‑
location. Under normal conditions, Nrf2 is anchored in the
cytoplasm by Kelch‑like ECH‑associated protein 1 (Keap1).
However, when cells are exposed to inducing stimuli, Nrf2
is activated, released from Keap1 and transported into the
nucleus (33). Nrf2 then combines with the antioxidant response
element (ARE) in the promoter region of downstream target
genes, activating the transcription of target genes and transducing antioxidant signals (34). To clarify the impact of WKN
treatment on Nrf2 transcriptional activity, changes in Nrf2
content and nuclear localization after WKN treatment were
assessed in the present study. Immunofluorescence staining
revealed that the Nrf2 content of cells was markedly increased
following WKN treatment and that Nrf2 protein was translocated into the nucleus (Fig. 5C).
Nrf2 silencing inhibits the protective effect of WKN on
GES‑1 cells. To further confirm that the growth‑promoting
effect of WKN on gastric mucosa epithelial cells was via
the upregulation of Nrf2 and associated signaling pathways,
a lentiviral‑mediated Nrf2 gene knockdown GES‑1 cell line
was established. Western blotting revealed that Nrf2 protein
expression decreased most markedly in shNrf22‑3 silenced
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Figure 3. WKN treatment increases the expression of GSTP1 and SOD2 in GES‑1 cells. GSTP1 and SOD2 (A) mRNA and (B) protein levels in GES‑1 cells
after 24 h treatment with 2.5 µmol/ml DD or WKN at. GES‑1 cells treated with PBS were used as the control group and all results were normalized to the
control. *P<0.05, ***P<0.001 and ****P<0.0001 vs. the control group. ∆∆∆ P<0.001 and ∆∆∆∆ P<0.0001 vs. the DD group. #P<0.05, ###P<0.001 and ####P<0.0001
vs. the 0.025 mg/ml WKN group. WKN, weikangning; GSTP1, glutathione‑S‑transferase P; SOD2, superoxide dismutase 2; DD, domperidone.

Figure 4. GSH content, SOD activity and MDA content of GES‑1 cells following 24 h treatment with 2.5 µmol/ml DD or 0.025 mg/ml WKN. GES‑1 cells
treated with PBS solution were used as the control group. **P<0.01 and ****P<0.0001 vs. the control group. GSH, glutathione; SOD, superoxide dismutase; MDA,
maleic dialdehyde; WKN, weikangning; DD, domperidone.

cells compared with the shMock cells (Fig. 1). Thus, these
shNrf cells were taken forward for further experiments.
In the shMock cells, treatment with 0.025 mg/ml WKN
significantly increased the mRNA and protein expression of
GSTP1 and SOD2 compared with the control group (P<0.05;
Fig. 6A and B). In shNrf2 cells, the mRNA and protein
expression of GSTP1 and SOD2 were significantly lower
compared with the shMock cells, before and after WKN treatment (P<0.01; Fig. 6A and B). Furthermore, when Nrf2 was
knocked down, the GSH content and SOD activity of GES‑1
cells decreased significantly, and MDA increased significantly,
compared with the shMock group (P<0.001; Fig. 6C‑E),

despite treatment with WKN. These results indicate that the
protective effect of WKN against cellular oxidative stress was
significantly impaired by Nrf2 silencing.
The proliferative abilities of shNrf2 and shMock cells
were examined using the MTS assay following 4, 48 and
96 h of treatment with 0.025 mg/ml WKN (Fig. 6F). This
demonstrated that 48 h of WKN treatment promoted the
proliferation of shMock cells, but this effect decreased
over time. Under Nrf2 silencing conditions, GES‑1 cell
g row t h was slower ( P< 0. 0 0 01; cont rol + sh Nr f 2
vs. control + shMock group). Furthermore, with Nrf2
knockdown, the effect of 48 h WKN treatment cell
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Figure 5. WKN treatment increases the transcription of Nrf2 in GES‑1 cells. Transcription of (A) Nrf2 following 0.025 mg/ml WKN treatment for 0.5, 2, 4 and
8 h, and (B) Nrf2 downstream target genes, GCLC, HO‑1, GCLM and NQO1 in GES‑1 cells following 0.025 mg/ml WKN treatment for 4 h. The results were
normalized to the PBS control. (C) Representative immunofluorescence images of Nrf2 staining in GES‑1 cells after 24 h treatment with 0.025 mg/ml WKN
or PBS solution. White stars indicate accumulated Nrf2 in the cytoplasm and white arrows indicate translocated Nrf2 in the nucleus. Magnification, x800.
*
P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 vs. the control group. WKN, weikangning; Nrf2, nuclear factor erythroid 2 like 2; GCLC, glutamate cysteine
ligase catalytic subunit; HO‑1, heme oxygenase 1; GCLM, glutamate cysteine ligase modifier subunit; NQO1, NADPH dehydrogenase quninone 1.

proliferation was significantly reduced (P<0.00 01;
WKN + shNrf2 vs. WKN + shMock group).
Discussion
In a previous study, our group investigated the pathogenesis
of FD, in addition to the therapeutic effect of WKN and the
underlying molecular mechanism of this effect, from the
perspective of proteomic analysis in a rat model of FD (12).
It was demonstrated that the expression levels of GSTP1 and
SOD2 were significantly upregulated in the WKN treatment
group compared with the disease model group.
GSH‑dependent and SOD enzymes are important cellular
antioxidants that serve vital roles in resisting the damaging
effects of external toxin and ROS (35,36). GSTP1 is a member
of the GSTP family, a subtype of GSTs. GSTP1 is capable of
catalyzing the conjugate connections between GSH and charged
complexes, so as to serve the function of detoxification. A

previous study reported that different genotypes of the GSTP1
exon 5 are associated with intestinal metaplasia in the pre‑gastric
cancer stage, and positively interact with Helicobacter pylori
infection in the intestinal metaplasia (37). SOD2 is primarily
sub‑cellularly located in the mitochondria and is an important
component of the cellular antioxidant system (38‑40). SOD2
maintains the balance between oxidation and antioxidation by
reducing superoxides, including the superoxide anion (36). It
has previously been reported that SOD2 knockout may be lethal
in animals (41), whereas SOD2 overexpression significantly
reduces lipid peroxidation, represses protein nitrosylation of
protein tyrosine residues, inhibits cellular apoptosis and ameliorates ischemic tissue injury (42). In addition, SOD2 is able to
inhibit the activation of the mitochondrial‑dependent apoptotic
signaling pathway by inhibiting the transfer of cytochrome
c from mitochondria to the cytoplasm (43‑45). There is also
evidence that SOD2 serves a more important role than SOD1 in
cellular resistance to stress and injury (46).
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Figure 6. Nrf2 knockdown inhibits the protective effects of WKN on GES‑1 cells. After 24 h treatment with 0.025 mg/ml WKN or PBS solution, the levels of
expression of GSTP1 and SOD2 (A) mRNA and (B) protein, (C) GSH content, (D) SOD activity and (E) MDA content in shMock cells and shNrf2 cells were
asessed. Results were normalized to the values of the control + shMock group. (F) Effect of 0.025 mg/ml WKN treatment on the growth of GES‑1 cells prior
to and after Nrf2 knockdown was assessed using the MTT assay. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001 vs. the control + shMock group. ##P<0.01,
###
P<0.001, ####P<0.0001 vs. the 0.025 mg/ml WKN + shMock group. Nrf2, ��������������������������������������������������������������������������������
nuclear factor erythroid 2 like 2; ���������������������������������������������
WKN, weikangning; GSTP1, glutathione‑S‑transferase P; SOD2, superoxide dismutase 2; GSH, glutathione; MDA, maleic dialdehyde; shRNA, short hairpin RNA.

Changes in the expression levels of GSTP1 and SOD2 in
the FD rat model in our previous study suggested that oxidative
stress may participate in the pathogenesis of FD (12). Previous
studies have indicated that oxidative stress in GI tissues may
serve an important role in the development of gastric damage
and disorders, and the protective effects of certain pharmacological agents were reported to be associated with a reduction

in oxidative stress (47‑49). In the present study, SOD2 and
GSTP1 were identified to be upregulated at the transcriptional and protein levels in human mucosal epithelial cells
after WKN treatment. Furthermore, the GSH content, SOD
activity and MDA content measured in the WKN‑treated cells
indicated that the WKN decreased oxidative stress in gastric
mucosal epithelial cells.
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The results of the present study suggest that WKN promotes
the expression and thus effects of antioxidant enzymes via the
Nrf2/ARE signaling pathway, which was supported by the results
of lentiviral‑mediated Nrf2 knockdown. Nrf2 is an important
transcription factor that exerts a protective effect against oxidative and chemical stress, through regulating the expression of
antioxidant proteins via ARE interaction (35). The Nrf2‑ARE
signaling pathway is the main pathway that induces cell resistance to damage by exogenous substances and oxidative stress.
Nrf2 also serves key roles in maintaining homeostasis of the cell
microenvironment, and promoting cell growth and reproduction (50,51). Nrf2 is able to protect the lungs, liver and digestive
tract without cell or organ specificity (52,53). Consequently,
Nrf2 has great therapeutic potential for multi‑organ protection (53,54). The results of the present study demonstrated
that Nrf2 may serve an essential role in GES‑1 cells, as Nrf2
knockdown has an impact on growth and antioxidant activity.
However, it remains to be elucidated whether the protective
effect of WKN is entirely dependent on Nrf2 signaling.
In conclusion, combined with our previous research,
the results of the present study suggest that the therapeutic
efficacy of the TCM WKN as a treatment for FD relies on
oxidative stress alleviation in GES‑1 cells, which is mediated
by Nrf2 signaling. The results of the present study also indicate indirectly that oxidative stress may be associated with the
pathogenesis and development of GI disorders, something that
has been proposed previously but is lacking in evidence (55,56).
The beneficial effects of TCMs on inflammatory GI diseases
and associated tumorigenesis have been extensively studied,
with certain reports suggesting that these treatments act via
modulating the Nrf2 signaling pathway (57,58). Future studies
should test the results of the present study using an in vivo
model of FD to increase the understanding of the pathology of
functional GI disorders and potentially provide a clinical basis
for WKN as a treatment for FD.
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